Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSCR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATOH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CLEC4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM76A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMSY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on